Merit Financial Group’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$506K Sell
14,285
-528
-4% -$15.6K ﹤0.01% 1487
2026
Q1
$410K Buy
+14,813
New +$381K ﹤0.01% 1486

Other funds holding ROIV

Merit Financial Group's ROIV Position: Q2 2026 in Review

Merit Financial Group reduced its Roivant Sciences (ROIV) stake by 3.6% in Q2 2026, selling an estimated $15.6K and leaving 14,285 shares worth $506K. The position accounts for ﹤0.01% of the portfolio, ranked #1487.

Merit Financial Group first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. 65 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Merit Financial Group held 14,285 shares of Roivant Sciences worth $506K as of Q2 2026.
  • Merit Financial Group sold 528 Roivant Sciences shares in Q2 2026, an estimated $15.6K.
  • Roivant Sciences made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #1487 holding.
  • Merit Financial Group first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • 65 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.